Ledger.Open graph →
SEC Form D · Amendment · filed May 15, 2024

Retension Pharmaceuticals, Inc

Offering
$11.0M
Sold
$10.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MCLEAN, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Donald Olds · McLean, VADirectorMichael Berendt · McLean, VADirectorEric Keller · McLean, VAExec · DirectorEric Keller · McLean, VAExec · DirectorMichael Berendt · McLean, VADirectorDonald Olds · McLean, VADirectorZack S. Zavalydriga · BOSTON, MADirectorJoe S. Atencio · BOSTON, MADirectorJennifer S. Roach · BOSTON, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗